Alembic Pharmaceuticals has reported results for second quarter ended September 30, 2022.
The company has reported a rise of 2.31% in its net profit at Rs 146.44 crore for the quarter under review as compared to Rs 143.13 crore for the same quarter in the previous year. Total income of the company increased by 10.94% at Rs 1354.88 crore for Q2FY23 as compared Rs 1221.32 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported fall of 18.68% in its net profit at Rs 133.35 crore for the quarter under review as compared to Rs 163.99 crore for the same quarter in the previous year. However, total income of the company increased by 12.35% at Rs 1475.34 crore for Q2FY23 as compared Rs 1313.19 crore for the corresponding quarter previous year.
